Allergan rose $3.66 or 2.9 percent, to $131.46. Baxter International Inc. rose$. 09 or. 1 percent, to $73.45. Boston Scientific Corp. rose$. 15 or 1.1 percent, to $13.50.» Read More
ZURICH, Dec 29- The world's largest dental implant maker, Straumann, will cut the price of its standard titanium implants by around 15 percent next year in Germany, Austria and Switzerland, the firm's chief executive told a Swiss newspaper on Sunday.
Inform Fitness uses a 20-minute high intensity workout each week. Founder Adam Zickerman puts "Fast Money" trader John Najarian to work. Intensity is key to results, says Zickerman.
The breach came to light last month when the FDA sent letters to users of an online system at the Center for Biologics Evaluation and Research. The letters said the breach was detected by the FDA on Oct. 15 and that it resulted in the theft of usernames, phone numbers, email addresses and passwords.
The Food and Drug Administration, in a statement to healthcare professionals, said it is concerned that women will believe misleading claims about a nipple aspirate test and not get mammograms or other needed breast imaging tests or biopsies.
Dec 11- An advisory panel of medical experts voted on Wednesday to recommend that U.S. health regulators approve an experimental stroke-prevention device made by Boston Scientific Corp. The FDA typically follows the recommendations of its expert advisory panels, but is not obligated to do so.
The FDA released documents about the device, called Watchman, ahead of a meeting on Wednesday of outside medical experts who will consider its risks and benefits and then recommend whether the FDA should approve the product for use in patients.
Dec 9- Boston Scientific Corp's anti-stroke device did not meet one measure of success in a clinical study of the implant, but other data must be considered when determining overall safety and effectiveness, staff members of the U.S. Food and Drug Administration stressed on Monday.
The FDA the following month declared a Class II recall on the devices, citing a "remote" chance of severe adverse consequences or death due to the product flaw. FDA spokeswoman Jennifer Rodriguez said the agency issued its safety advisory on Tuesday because Philips has been unable to reach a significant number of its customers, to point out the potential risk.
In a warning letter dated Nov. 22 and released on Monday, the FDA said it considers the company's product a medical device that therefore requires regulatory clearance, "as FDA has explained to you on numerous occasions."
Nov 21- Activist investor Carl Icahn disclosed a 12.63 percent stake in medical device maker Hologic Inc, prompting the company to adopt a shareholder rights plan to protect itself from hostile takeovers. Shares of Hologic, which makes screening tests for cancer and other diseases, rose 3 percent in late morning trading.
Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover
Nov 21- Activist investor Carl Icahn reported a 12.63 percent stake in medical device maker Hologic Inc, prompting the company to adopt a shareholder rights plan to protect itself from hostile takeovers.
Nov 19- Medtronic Inc reported higher quarterly earnings on Tuesday as stronger sales of its implantable devices to treat abnormal heart rhythms offset weakness in its spinal products business.
Nov 18- Medical device maker CareFusion Corp said it will buy GE Healthcare's respiratory care and anesthesiology products business, Vital Signs, for $500 million.
Nov 12- Johnson& Johnson will pay more than $4 billion to settle thousands of lawsuits over its recalled defective hip implants, Bloomberg reported late on Tuesday, citing three people familiar with the deal. Johnson& Johnson declined to comment on the report.
WASHINGTON, Nov 5- The U.S. Supreme Court on Tuesday heard arguments in a case of warring legal doctrines raised by a heart pacemaker patent fight between giant medical devices company Medtronic Inc and privately owned Mirowski Family Ventures LLC.
Medtronic is preparing to launch the product in the United States, pending regulatory approval. Medtronic said it expects to launch the product in the United States for use in extreme-risk patients before its fiscal year ends in April 2014, noting that the U.S. Food and Drug Administration determined it has sufficient information to evaluate the device.
Oct 28- Edwards Lifesciences Corp on Monday reported higher-than-expected quarterly earnings, but investors were disappointed with the pace of U.S. sales of its newest artificial heart valves, sending its shares down more than 4 percent.
Oct 28- Edwards Lifesciences Corp on Monday reported higher-than-expected quarterly earnings as it benefited from strong sales of artificial heart valves that are implanted without major invasive surgery. Third-quarter net income rose to $77 million, or 68 cents per share, from $69 million, or 58 cents per share, a year earlier.
Oct 25- The U.S. Food and Drug Administration has approved Abbott Laboratories' MitraClip medical device, used to stop heart valve leakage in patients deemed unable to endure valve repair through open heart surgery, the company said on Friday. "We think longer term in the U.S., could be a $500 million product," said RBC Capital Markets analyst Glenn Novarro.